These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12727081)

  • 1. Relevance of antimicrobial agent-induced endotoxin release from in vitro cultured Escherichia coli and in vivo experimental infection with Gram-negative bacilli.
    Tsumura H; Hiyama E; Kodama T; Sueda T; Yokoyama T
    Int J Antimicrob Agents; 2003 May; 21(5):463-70. PubMed ID: 12727081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
    Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; D'Amato G; Orlando F; Sisti V; Kamysz W; Silvestri C; Naldoski P; Lukasiak J; Saba V; Scalise G
    J Antimicrob Chemother; 2004 Sep; 54(3):654-60. PubMed ID: 15294887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of different classes antimicrobial agents on plasma endotoxin activity.
    Nitsche D; Schulze C; Oesser S; Dalhoff A; Sack M
    Arch Surg; 1996 Feb; 131(2):192-9. PubMed ID: 8611078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes.
    Dofferhoff AS; Esselink MT; de Vries-Hospers HG; van Zanten A; Bom VJ; Weits J; Vellenga E
    J Antimicrob Chemother; 1993 Mar; 31(3):373-84. PubMed ID: 8486571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a recombinant endotoxin neutralizing protein in rabbits with Escherichia coli sepsis.
    Saladino R; Garcia C; Thompson C; Hammer B; Parsonnet J; Novitsky T; Siber G; Fleisher G
    Circ Shock; 1994 Feb; 42(2):104-10. PubMed ID: 8013061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial-induced endotoxin and cytokine activity in an in vitro model of septicemia in foals.
    Bentley AP; Barton MH; Lee MD; Norton NA; Moore JN
    Am J Vet Res; 2002 May; 63(5):660-8. PubMed ID: 12013465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis.
    Friedland IR; Jafari H; Ehrett S; Rinderknecht S; Paris M; Coulthard M; Saxen H; Olsen K; McCracken GH
    J Infect Dis; 1993 Sep; 168(3):657-62. PubMed ID: 8354907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis.
    Shenep JL; Mogan KA
    J Infect Dis; 1984 Sep; 150(3):380-8. PubMed ID: 6384378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1 beta.
    Kishi K; Hirai K; Hiramatsu K; Yamasaki T; Nasu M
    Antimicrob Agents Chemother; 1999 Mar; 43(3):616-22. PubMed ID: 10049276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Activity of Ceftriaxone, Ciprofloxacin, and Gentamicin as a Function of Bacterial Growth Rate Probed by Escherichia coli Chromosome Replication in the Mouse Peritonitis Model.
    Haugan MS; Løbner-Olesen A; Frimodt-Møller N
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis.
    Shenep JL; Barton RP; Mogan KA
    J Infect Dis; 1985 Jun; 151(6):1012-8. PubMed ID: 3889171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis.
    Cirioni O; Ghiselli R; Silvestri C; Kamysz W; Orlando F; Riva A; Kamysz E; Castelletti S; Rocchi M; Saba V; Scalise G; Giacometti A
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4351-5. PubMed ID: 18779356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose recombinant endotoxin neutralizing protein improves survival in rabbits, with Escherichia coli sepsis.
    Saladino RA; Stack AM; Thompson C; Sattler F; Novitsky TJ; Siber GR; Fleisher GR
    Crit Care Med; 1996 Jul; 24(7):1203-7. PubMed ID: 8674336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Kamysz W; Rocchi M; D'Amato G; Mocchegiani F; Silvestri C; Łukasiak J; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):207-16. PubMed ID: 15629532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.
    Matsuda T; Freeman TA; Hilbert DW; Duff M; Fuortes M; Stapleton PP; Daly JM
    Surgery; 2005 Jun; 137(6):639-46. PubMed ID: 15933632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats.
    Nelson D; Kuppermann N; Fleisher GR; Hammer BK; Thompson CM; Garcia CT; Novitsky TJ; Parsonnet J; Onderdonk A; Siber GR
    Crit Care Med; 1995 Jan; 23(1):92-8. PubMed ID: 8001394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lincomycin-induced endotoxin release in Escherichia coli sepsis: evidence for release in vitro and in vivo.
    Horii T; Kimura T; Nadai M; Kobayashi M
    Int J Infect Dis; 2000; 4(3):118-22. PubMed ID: 11179913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans.
    Mohamed M; Clabots C; Porter SB; Thuras P; Johnson JR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4638-45. PubMed ID: 27185805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in neutrophil death among beta-lactam antibiotics after in vitro killing of bacteria.
    Matsuda T; Saito H; Fukatsu K; Han I; Inoue T; Furukawa S; Ikeda S; Hidemura A; Kang W
    Shock; 2002 Jul; 18(1):69-74. PubMed ID: 12095137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.